Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Several modifiable risk factors, including increased blood pressure (BP), significantly contribute to cardiovascular risk in CCS. Therefore, optimal secondary prevention includes managing BP through lifestyle changes and pharmacological therapy.

Blood Pressure 52

Blood Pressure Pharmacology Document Risk Factors 52

DAIC

MAY 21, 2024

A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. Of 102,475 participants, 49.1% were female.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Hypertension Journal

AUGUST 5, 2024

Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Despite the widespread availability of both pharmacological and lifestyle therapeutic options, blood pressure control rates across the globe are worsening. Hypertension, Ahead of Print.

Hypertension 77

Hypertension Blood Pressure Pharmacology Risk Factors 77

Dr. Paddy Barrett

APRIL 5, 2024

Primordial prevention is changing the environment around you so you do not develop the risk factors for heart disease and, by extension, do not get the disease early in life. Blood Pressure Control High blood pressure is the risk factor associated with the greatest number of deaths worldwide.

Heart Disease 118

Heart Disease Coronary Artery Disease Heart attacks Heart Attack 118

Heart BMJ

JUNE 25, 2024

Despite the existence of well-established risk factors and effective pharmacological treatments for major cardiovascular disease (CVD), these conditions remain among the leading causes of premature death and disability, exerting a substantial burden on health systems worldwide.

Pharmacology 59

Pharmacology Blood Pressure Risk Factors Cardiovascular Disease 59

DAIC

MAY 16, 2024

Implementation of a multispecialty care team approach, including expertise in risk factor management, guideline directed medical therapies, wound and foot care and endovascular and surgical revascularization procedures, may improve outcomes for people with PAD. and Global Data From the American Heart Association.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Frontiers in Cardiovascular Medicine

MARCH 4, 2024

The complex development of atherosclerosis manifests as intimal plaque which occurs in the presence or absence of traditional risk factors. For cardiovascular disease, only low-density lipoprotein cholesterol and blood pressure are approved as surrogates for cardiovascular disease.

Plaque 59

Plaque Coronary Artery Disease Blood Pressure Cardiovascular Disease 59